Search research articles
Contact Us
Filters
Showing results (51-60 of 131) with videos related to
Page
of 14
Sort By:
Contact Dermatitis
|
May 2, 2000
Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin
L Martin, L Machet, N Gironet, et al.
Molecular Immunology
|
June 1, 1995
Repertoire cloning of a human IgG inhibitor of alpha IIB beta 3 function. The OG idiotype
F Ishida, Y Gruel, E Brojer, et al.
Thrombosis Research
|
September 1, 1992
Anticardiolipin antibodies in heparin-associated thrombocytopenia
Y Gruel, A Rupin, H Watier, et al.
Thrombosis Research
|
March 1, 1988
Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns
P Moalic, Y Gruel, G Body, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 26, 2002
Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variant
B Delahousse, M Gilbert, F Nicham, et al.
Cahiers D'Anesthesiologie
|
January 1, 1994
[Peranesthetic acute respiratory failure disclosed by prone position in a child with mediastinal adenopathy]
C Camus-Kerébel, A David-Manach, Y Gruel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 10, 1998
Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays
B Delahousse, S Iochmann, C Pouplard, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 7, 2001
Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics
B Delahousse, F Maillot, I Gabriel, et al.
Chirurgie Pediatrique
|
January 1, 1983
[Therapeutic approach to bilateral hepatoblastoma]
J M Babut, E Le Gall, D Bourdelat, et al.
Scandinavian Journal of Immunology
|
March 1, 1996
Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers
B Khalfoun, G Thibault, M Lacord, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 131) with videos related to
Sort By:
Page
of 14
Contact Dermatitis
|
May 2, 2000
Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin
L Martin, L Machet, N Gironet, et al.
Molecular Immunology
|
June 1, 1995
Repertoire cloning of a human IgG inhibitor of alpha IIB beta 3 function. The OG idiotype
F Ishida, Y Gruel, E Brojer, et al.
Thrombosis Research
|
September 1, 1992
Anticardiolipin antibodies in heparin-associated thrombocytopenia
Y Gruel, A Rupin, H Watier, et al.
Thrombosis Research
|
March 1, 1988
Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns
P Moalic, Y Gruel, G Body, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 26, 2002
Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variant
B Delahousse, M Gilbert, F Nicham, et al.
Cahiers D'Anesthesiologie
|
January 1, 1994
[Peranesthetic acute respiratory failure disclosed by prone position in a child with mediastinal adenopathy]
C Camus-Kerébel, A David-Manach, Y Gruel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 10, 1998
Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays
B Delahousse, S Iochmann, C Pouplard, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 7, 2001
Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics
B Delahousse, F Maillot, I Gabriel, et al.
Chirurgie Pediatrique
|
January 1, 1983
[Therapeutic approach to bilateral hepatoblastoma]
J M Babut, E Le Gall, D Bourdelat, et al.
Scandinavian Journal of Immunology
|
March 1, 1996
Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers
B Khalfoun, G Thibault, M Lacord, et al.
Page
of 14